CJC-1295 (NO Dac)/Ipamorelin

The CJC-1295 (No DAC) / Ipamorelin blend is one of the most researched GH secretagogue combinations in peptide science — pairing two complementary mechanisms into a single, synergistic vial. CJC-1295 (No DAC) stimulates GHRH

receptors to amplify GH pulse amplitude, while Ipamorelin mimics ghrelin to trigger GH release through a separate receptor pathway. Together they produce a stronger, more sustained GH response than either compound alone — without the cortisol or prolactin elevation associated with less selective secretagogues.

CJC-1295 (No DAC) — A modified GHRH analogue that stimulates pituitary GHRH receptors, increasing the amplitude of natural GH pulses while preserving physiological feedback regulation.

Ipamorelin — A selective GHS-R1a agonist that triggers pulsatile GH release through the ghrelin receptor pathway, with a highly selective profile that avoids unwanted hormonal side effects.

Research Areas: GH axis stimulation · Lean mass & body composition · Bone density & connective tissue · Metabolic regulation · Recovery & regeneration · Anti-aging & longevity biology

For Research Purposes Only.